Source: 4-TRADERS

Precision Oncology: ACT Oncology President Named EY Entrepreneur of the Year(R) New Jersey Finalist

(4-traders.com) FLEMINGTON, NJ / ACCESSWIRE / June 8, 2015 / ACT Oncology (ACT), an oncology-specialist, clinical research organization (CRO), announced today that Patricia Devitt-Risse, Pharm. D, President of the company, has been named a finalist for the Ernst & Young Entrepreneur Of The Year(R) 2015 Award for the state of New Jersey. With selection...http://www.4-traders.com/news/ACT-Oncology-President-Named-EY-Entrepreneur-of-the-YearR-New-Jersey-Finalist--20507536/

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
100-250
Patricia Devitt Risse's photo - President of Precision Oncology

President

Patricia Devitt Risse

CEO Approval Rating

73/100

Read more